AUROPHARMA vs RELIANCE
Head-to-head DCF comparison · Aurobindo Pharma Limited vs Reliance Industries
Model Favors
RELIANCE shows a larger model margin of safety
Leads on 3 of 4model metrics · not investment advice
AUROPHARMA
Aurobindo Pharma Limited
Pharma
₹1,473
Near Fair ValueRELIANCE
Reliance Industries
Oil & Gas
₹1,293
Near Fair Value| Metric | AUROPHARMA | RELIANCE |
|---|---|---|
| Verdict | Near Fair Value | Near Fair Value |
| YieldIQ Score | 59/100 | 67/100 |
| Fair Value | ₹1,546 | ₹1,535 |
| Current Price | ₹1,473 | ₹1,293 |
| Discount to FV | +5.0% | +18.8% |
| Moat | Narrow | Moderate |
| Piotroski F-Score | 7/9 | 4/9 |
| ROE | 9.3% | 8.9% |
| Debt / Equity | 0.21 | 0.37 |
| EV / EBITDA | 11.8× | 9.8× |
| Market Cap | ₹84,742 Cr | ₹17.50 Lakh Cr |
Run the full interactive analysis
DCF sliders, sensitivity tables, peer screens, watchlists — free to start.
Sign up free →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst.